A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-07-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-01-198937PMID 19332766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic lymphocytic leukaemia.

  2008cited by this paper
• The role of E2A in B cell chronic lymphocytic leukemia

  2008cited by this paper
• Murine models of chronic lymphocytic leukaemia: role of microRNA‐16 in the New Zealand Black mouse model

  2007cited by this paper
• Chromosomal reinsertion of broken RSS ends during T cell development

  2007cited by this paper
• In Vivo Reinsertion of Excised Episomes by the V(D)J Recombinase: A Potential Threat to Genomic Stability

  2007cited by this paper
• Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

  2007cited by this paper
• Antisense Intergenic Transcription Precedes Igh D-to-J Recombination and Is Controlled by the Intronic Enhancer Eμ

  2007cited by this paper
• Pathology of chronic lymphocytic leukemia: an update.

  2007cited by this paper
• Genetic alteration associated with chronic lymphocytic leukemia

  2007cited by this paper
• Oncogenic potentials of the human polyomavirus regulatory proteins

  2007cited by this paper
• Leukemia

  2007cited by this paper
• Regulation of SV40 large T-antigen stability by reversible acetylation

  2006cited by this paper
• High Prevalence of SV40 Infection in Patients with Nodal Non-Hodgkin's Lymphoma But Not Acute Leukemia Independent of Contaminated Polio Vaccines in Taiwan

  2006cited by this paper
• B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.

  2006cited by this paper
• Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis

  2005cited by this paper
• Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

  2005cited by this paper
• SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure.

  2005cited by this paper
• Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes

  2005cited by this paper
• SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

  2005cited by this paper
• New concepts in the regulation of an ancient reaction: transposition by RAG1/RAG2

  2004cited by this paper
• Selection during development of VH11+ B cells: a model for natural autoantibody‐producing CD5+ B cells

  2004cited by this paper
• Presence of Simian Virus 40 DNA Sequences in Human Lymphoid and Hematopoietic Malignancies and Their Relationship to Aberrant Promoter Methylation of Multiple Genes

  2004cited by this paper
• Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis.

  2004cited by this paper
• In vivo transposition mediated by V(D)J recombinase in human T lymphocytes

  2003cited by this paper
• Simian virus 40 in human cancers.

  2003cited by this paper
• Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

  2003cited by this paper
• Presence of simian virus 40 DNA sequences in human lymphomas.

  2002cited by this paper
• SV40 and human tumours: myth, association or causality?

  2002cited by this paper
• Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

  2002cited by this paper
• Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia.

  2002cited by this paper
• Cellular transformation by SV40 large T antigen: interaction with host proteins.

  2001cited by this paper
• V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma.

  2000cited by this paper
• V(D)J recombinase-mediated transposition of the BCL2gene to the IGH locus in follicular lymphoma

  2000cited by this paper
• Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity.

  2000cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma.

  1999cited by this paper
• Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.

  1999cited by this paper
• p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis.

  1998cited by this paper
• Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5 + B cells.

  1998cited by this paper
• Identification of SV40 T-antigen mutants that alter T-antigen-induced chromosome damage in human fibroblasts.

  1998cited by this paper
• Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system

  1998cited by this paper
• 3' IgH enhancer elements shift synergistic interactions during B cell development.

  1998cited by this paper
• p 53 Expression in B-Cell Chronic Lymphocytic Leukemia : A Marker of Disease Progression and Poor Prognosis

  1998cited by this paper
• DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations.

  1998cited by this paper
• Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.

  1997cited by this paper
• Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage.

  1996cited by this paper
• Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer.

  1994cited by this paper
• Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53.

  1994cited by this paper
• Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.

  1989cited by this paper
• Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre‐B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.

  1987cited by this paper
• Expression of the T1 (CD5, p67) surface antigen in B‐CLL and B‐NHL and its correlation with other B‐cell differentiation markers

  1986cited by this paper
• Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.

  1986cited by this paper

• Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019–2024)

  2025cites this paper
• Structural Complementarity of Bruton’s Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases

  2023cites this paper
• Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice.

  2022cites this paper
• Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B‐cell receptor signaling in mice

  2021cites this paper
• Concurrent Adjacent Merkel Cell Carcinoma and Chronic Lymphocytic Leukemia without Simultaneous Merkel Cell Polyomavirus Detection: A Case Series

  2021cites this paper
• Notch Signaling Promotes Disease Initiation and Progression in Murine Chronic Lymphocytic Leukemia.

  2020cites this paper
• Association Between Simian Virus 40 and Human Tumors

  2019cites this paper
• Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival

  2019influential citation
• Signal Transduction Pathways in Chronic Lymphocytic Leukemia

  2019cites this paper
• Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease

  2019cites this paper
• Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency

  2018influential citation
• Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice.

  2018cites this paper
• Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling

  2017influential citation
• Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.

  2016cites this paper
• Targeting Signaling Pathways in Chronic Lymphocytic Leukemia.

  2016cites this paper
• Analyse des Transkriptionsfaktors NFAT2 in der Pathogenese der CLL

  2015cites this paper
• Merkel cell carcinoma: is this a true carcinoma?

  2014cites this paper
• SV40 TAg mouse models of cancer.

  2014cites this paper
• Targeting Bruton's tyrosine kinase in B cell malignancies

  2014cites this paper
• Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy.

  2014cites this paper
• The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.

  2013cites this paper
• Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector.

  2013cites this paper
• Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia.

  2013influential citation
• Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cells.

  2013cites this paper
• ATM mutant cellular phenotype in B-cell chronic lymphocytic leukaemia : clinical consequences and therapeutic implications

  2013cites this paper
• The genomic landscape of chronic lymphocytic leukemia: clinical implications

  2013cites this paper
• Delineation of molecular events that occur in a PKCα-KR-mediated murine model of CLL

  2012influential citation
• The molecular regulation of apoptosis in b-cell neoplasms

  2012influential citation
• The microenvironment and treatment resistance in chronic lymphocytic leukemia

  2012cites this paper
• Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan.

  2012cites this paper
• The role of B cell receptor stimulation in CLL pathogenesis.

  2012cites this paper
• Mouse Models of Chronic Lymphocytic Leukemia

  2012cites this paper
• Simian virus 40 transformation, malignant mesothelioma and brain tumors

  2011cites this paper
• Therapeutic Modalities and New Molecular Targets in MDS

  2011cites this paper
• New Strategies in Diffuse Large B-cell Lymphoma: Translating Findings from Gene Expression Analyses into Clinical Practice

  2011cites this paper
• Hypomethylating agents and other novel strategies in myelodysplastic syndromes.

  2011cites this paper
• REGULACIÓN Y FUNCIÓN DE LA METALOPROTEINASA DE MATRIZ (MMP-9) EN LA LEUCEMIA LINFOCÍTICA CRÓNICA-B Y SU PAPEL EN LA PATOGÉNESIS DE LA ENFERMEDAD.

  2010cites this paper
• An overview of chronic lymphocytic leukaemia biology.

  2010cites this paper
• Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells.

  2010cites this paper
• Mighty mouse.

  2009cites this paper